Grown Rogue International (GRUSF) FCF Payout Ratio (2013 - 2018)
Grown Rogue International's (GRUSF) quarterly FCF Payout Ratio came in at 0.53 in Q2 2018, up 412.22% year-on-year from 0.1 in Q2 2017, and up 412.22% quarter-over-quarter from 0.1 in Q2 2017.
Grown Rogue International (GRUSF) FCF Payout Ratio (2013 - 2018) Analysis & Trends
Grown Rogue International's FCF Payout Ratio history runs 6 years deep, the most recent figure standing at 0.53 for Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.77 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -10.50 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.40 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2018 | 0.53 |
| May 31, 2017 | 0.10 |
| Nov 30, 2016 | -0.24 |
| May 31, 2016 | -1.49 |
| Feb 29, 2016 | -0.18 |
| Nov 30, 2015 | -0.19 |
| May 31, 2015 | 0.04 |
| Feb 28, 2015 | -0.27 |
| Nov 30, 2014 | -0.09 |
| May 31, 2014 | 0.18 |
| Feb 28, 2014 | -1.74 |
| Nov 30, 2013 | -1.12 |